Zeus Capital’s breadth of expertise, covering the range of funding options and transaction structures across public and private markets, enables us to provide our clients with bespoke solutions, tailor made for them.

Advice is provided by a multi-disciplinary team, covering corporate finance, corporate broking and sales, supported by research analysts with deep sector knowledge.


Including the likes of Quantum Pharma and, we have been Nominated Advisor and sole broker on a range of high profile IPOs, raising significant equity funding for existing shareholders and development capital within the company.

In this role, we advise and raise equity and debt funding for companies looking to list on AIM. We have also worked successfully alongside other advisors in the role of lead and/or joint broker on both AIM and Main Market listings.

Our experience and integrated team of corporate financiers, equity sales and research analysts allows us to project manage all aspects of the float process. Zeus Capital has a demonstrable track record of efficient and successful IPO delivery. Our approach involves significant, fully contingent up-front advice from the Zeus Capital team and test marketing to determine investor appetite and pricing. The result is to provide all stakeholders in the process with high levels of transparency and confidence in a successful outcome.